Grant Zeng, CFA, Senior Biotechnology Analyst
Grant Zeng, CFA has 8 plus years professional experience in equity research and analysis. He is currently a senior biotech analyst with Zacks Investment Research Inc. since March 2006.
Before joining Zacks, Grant worked for TheStreet.com as a biotech analyst from 2005-2006. From September 2001 to December 2003, Grant worked for China Pacific Insurance Co. as an equity/fund analyst. Grant was a healthcare equity analyst with Young & Partners, LLC from August 2000 to September 2001. Grant also has teaching and researching experience in pharmaceutical science.
Grant Zeng obtained his MBA with a major in Finance in 2000 from McMaster University, Canada. He also holds a Master of Science in Biochemistry from the University of Western Ontario, Canada; Master of Pharmacology and Bachelor of Medicine from Second Military Medical University, China.
Grant Zeng is a holder of the Chartered Financial Analyst (CFA) designation, and series 7, 86/87 licensed.